Pluri Inc. (PLUR)
NASDAQ·Healthcare·Biotechnology
$1.23
-1.59%
Mkt Cap $27.51M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$12.00
Range $12.00 – $12.00
Implied Upside
+875.5%
Consensus $12.00 vs current $1.23
NASDAQ·Healthcare·Biotechnology
$1.23
-1.59%
Mkt Cap $27.51M
No recent rating data.
Price Target (1 analysts)
$12.00
Range $12.00 – $12.00
+875.5%
Consensus $12.00 vs current $1.23